| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 07/17/2002 | CN1087733C Synthetic process of benzobenzyl ammonium amide |
| 07/16/2002 | US6420603 Process for the preparation of n,n'-bis[2,3-dihydroxypropyl]-5-[(hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420426 Used to treat complications from diabetes mellitus |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053269A1 Method of separating isotopes |
| 07/11/2002 | WO2001034639A3 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | CN1357536A Linking molecule for selective metallation of nucleic acid and its application |
| 07/09/2002 | US6417397 Drug delivery, bioavailability; prodrugs |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051796A1 Amide derivatives |
| 07/04/2002 | WO2002032856A3 Insecticidal 1,8-naphthalenedicarboxamides |
| 07/03/2002 | EP1219659A1 Amphipathic compound having dendritic structure |
| 07/03/2002 | EP1219596A1 Salicylamide derivatives |
| 07/03/2002 | EP1218336A2 Melanin concentrating hormone antagonist |
| 07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
| 07/02/2002 | US6414122 Biochemical conjugation to proteins, peptides, hormones, polysaccharides, nucleic acids, liposomes, radionuclides, haptens, and toxins |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | CA2124315C Nitroaniline derivatives and their use as antitumor agents |
| 07/02/2002 | CA2040204C Chelating compounds and their use |
| 06/27/2002 | WO2002050100A2 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery |
| 06/27/2002 | WO2002050077A2 Triazolopyrimidines |
| 06/27/2002 | WO2002050056A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002018323A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 06/27/2002 | WO2002009648A3 Antimicrobial biaryl compounds |
| 06/27/2002 | WO2001018171A3 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 06/27/2002 | US20020082302 Reacting tetrahydrofuan-imidazoline compound with metal organic derivative of 1-(3-R1-4-R2-phen-1-yl)- 2-R3-3-halogen propanes; removal of the pseudoephedrine protecting group and -OH group, reaction with amine and removal of protecting group |
| 06/27/2002 | US20020082262 Regulate the cellular transport proteins P- glycoprotein and MRP1 , which are the proteins believed to be responsible for multidrug resistance in cancer patients |
| 06/27/2002 | US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins |
| 06/27/2002 | DE10063115A1 Triazolopyrimidine Triazolopyrimidines |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/26/2002 | EP1217000A1 Inhibitors of factor Xa and factor VIIa |
| 06/26/2002 | EP1216236A1 Tryptase inhibitors |
| 06/26/2002 | EP1216225A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/26/2002 | EP1216095A1 Method for activating passivated iron |
| 06/25/2002 | US6410787 Process to prepare 2-aminoindan derivatives |
| 06/25/2002 | US6410594 Viricides |
| 06/25/2002 | US6410586 Modulators of protein tyrosine phosphatases (PTPases) |
| 06/25/2002 | US6410585 Therapy for non-insulin depend diabetes |
| 06/25/2002 | US6410558 Using indole or quinoline compound |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/20/2002 | WO2002048179A1 Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 |
| 06/20/2002 | WO2002048092A2 Compounds for altering mitochondrial function and cellular responses |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | DE10059418A1 Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, meta-substituted Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them |
| 06/19/2002 | EP1215201A2 Process for the preparation of aryloctanoyl amides |
| 06/19/2002 | EP1215200A1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same |
| 06/19/2002 | EP1215199A1 Linker molecules for selective metallisation of nucleic acids and their uses |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/18/2002 | US6407252 Reacting valine with bistrichloromethyl carbonate; cyclization |
| 06/18/2002 | US6407120 Administering pyridinylacetamide or phenylacetamide derivative to treat cardiovascular, eating, sexual, brain, nervous system, gastrointestinal, urogenital, psychological, and respiratory system disorders |
| 06/18/2002 | US6407065 VLA-4 antagonists |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002038530A8 Carboxylic acid type lipid |
| 06/13/2002 | WO2002004404A3 7,8 and 9-substituted tetracycline compounds |
| 06/13/2002 | US20020072639 Process for the crystallisation of sterically hindered compounds |
| 06/13/2002 | US20020072634 Reacting alpha -alkyl-alpha-aminonitrile with a base and the aldehyde to form Schiff base |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | US20020072069 Joining particle for use as diagnostic tools in genetic and chemical analysis |
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | CN1353702A Adamantane derivatives |
| 06/12/2002 | CN1353693A Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 06/11/2002 | US6403957 Nucleic acid reading and analysis system |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/06/2002 | WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/06/2002 | WO2002044137A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 06/06/2002 | WO2002044132A1 A process for the preparation of iopamidol and the new intermediates therein |
| 06/06/2002 | WO2002044125A1 A process for the preparation of n,n'-substituted 5-amino-1,3-benzenedicarboxamides |
| 06/06/2002 | WO2002004406A3 9-substituted minocycline compounds |
| 06/06/2002 | US20020068839 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| 06/06/2002 | US20020068802 Mono-and polyamides of perfluoroalkyl-substituted unsaturated acids |
| 06/05/2002 | EP1210321A1 Aminosalicylclic acid amides and their use for combating organisms that are harmful to plants |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210082A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 06/05/2002 | EP1039895B1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 06/05/2002 | EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
| 06/05/2002 | EP0923539B1 Compounds with growth hormone releasing properties |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 05/30/2002 | WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 05/30/2002 | WO2002042271A2 Biphenylcarboxamides useful as lipid lowering agents |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |